Cargando…

Targeted therapy with trastuzumab for epidermal growth factor receptor 2 (HER2)-positive advanced salivary duct carcinoma: A case report

Herein we report two cases of advanced and/or metastatic salivary duct carcinoma that relapsed after standard first-line chemotherapy. As overexpression of human epidermal growth factor receptor 2 (HER2) (3+) was observed by immunohistochemistry, the patients were treated with trastuzumab plus pacli...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gibo, Takahiko, Sekiguchi, Nodoka, Gomi, Daisuke, Noguchi, Takuro, Fukushima, Toshirou, Kobayashi, Takashi, Ozawa, Takesumi, Yamada, Shin-Ichi, Koizumi, Tomonobu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2019
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6589940/ https://www.ncbi.nlm.nih.gov/pubmed/31281644 http://dx.doi.org/10.3892/mco.2019.1875

Ejemplares similares

A Rare Distant Metastasis of Papillary Cystadenocarcinoma Arising from Maxillary Gingiva
por: Nishimaki, Fumihiro, et al.
Publicado: (2020)

Giant paratesticular liposarcoma with lung metastases: a case report and review of the literature
por: Noguchi, Takuro, et al.
Publicado: (2020)

Late and Rapid Relapse in Mediastinum from Testicular Germ Cell Tumor Stage I Over 13 Years after Surgery
por: Fukushima, Toshirou, et al.
Publicado: (2019)

Posterior mediastinal ganglioneuroblastoma in an adolescent: A case report and review
por: Sekiguchi, Nodoka, et al.
Publicado: (2019)

Intra‐oesophageal invasion of thymoma
por: Ozawa, Makiko, et al.
Publicado: (2019)

Successful and long-term response to trastuzumab plus paclitaxel combination therapy in human epidermal growth factor receptor 2-positive extramammary Paget's disease: A case report and review of the literature
por: Ichiyama, Takashi, et al.
Publicado: (2017)

Successful Salvage Chemotherapy with Streptozocin in a Patient with Mediastinal Atypical Carcinoid Tumor Who Had Relapsed after Various Prior Therapies
por: Fukushima, Toshirou, et al.
Publicado: (2018)

Response to lorlatinib on a patient with ALK‐rearranged non‐small cell lung cancer harboring 1151Tins mutation with uterine metastasis
por: Kobayashi, Takashi, et al.
Publicado: (2021)

Successful treatment with doxorubicin and ifosfamide for mediastinal malignant peripheral nerve sheath tumor with loss of H3K27me3 expression
por: Seno, Noriko, et al.
Publicado: (2017)

Fluorine‐18‐fluorodeoxyglucose‐positron emission tomography evaluation in metastatic bone lesions in lung cancer: Possible prediction of pain and skeletal‐related events
por: Gomi, Daisuke, et al.
Publicado: (2019)

Primary mediastinal germ cell tumors ‐ A retrospective analysis of >30 years of experience in a single institution
por: Koizumi, Tomonobu, et al.
Publicado: (2021)

Gastric cancer initially presenting as bone metastasis: Two case reports and a literature review
por: Gomi, Daisuke, et al.
Publicado: (2018)

CCR4-positive peripheral T-cell lymphoma presenting as eosinophilic pneumonia and developing from prolonged pustular psoriasis
por: Sekiguchi, Nodoka, et al.
Publicado: (2021)

Alectinib-Induced Alopecia in a Patient with Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer
por: Koizumi, Tomonobu, et al.
Publicado: (2016)

Relapsed and unresectable inflammatory myofibroblastic tumor responded to chemotherapy: A case report and review of the literature
por: Maruyama, Yasuhiro, et al.
Publicado: (2017)

ACTH‐producing thymic neuroendocrine tumor initially presenting as psychosis: A case report and literature review
por: Okumura, Taiki, et al.
Publicado: (2019)

Signet Ring Cell Carcinoma of Unknown Primary Origin Detected Incidentally by Lymph Node Purification for Thyroid Carcinoma
por: Handa, Hideo, et al.
Publicado: (2017)

HER2‐positive metastatic, parotid salivary duct carcinoma treated with a trastuzumab/pertuzumab‐based chemotherapy: A case report
por: Longo, Raffaele, et al.
Publicado: (2020)

Survival benefit of HER2-targeted or androgen deprivation therapy in salivary duct carcinoma
por: Kawakita, Daisuke, et al.
Publicado: (2022)

Adjuvant Treatment of the Salivary Duct Carcinoma with Her2 Overexpression
por: Berendika, Jelena, et al.
Publicado: (2021)

Serial Cancer Development Three Times in a Patient with Fanconi Anemia
por: Yanagisawa, Katsuya, et al.
Publicado: (2021)

Second-Line Treatment of HER2-Positive Salivary Gland Tumor: Ado-Trastuzumab Emtansine (T-DM1) after Progression on Trastuzumab
por: Corrêa, Tatiana Strava, et al.
Publicado: (2018)

Complete Response to Trastuzumab-Based Chemotherapy in a Patient with Human Epidermal Growth Factor Receptor-2-Positive Metastatic Salivary Duct Carcinoma ex Pleomorphic Adenoma
por: Kadowaki, Shigenori, et al.
Publicado: (2013)

Trastuzumab for Her2/neu-positive metastatic salivary gland carcinoma: Case report and review of the literature
por: Firwana, Belal, et al.
Publicado: (2012)

Synergy between trastuzumab and pertuzumab for human epidermal growth factor 2 (Her2) from colocalization: an in silico based mechanism
por: Fuentes, Gloria, et al.
Publicado: (2011)

Vasculogenic mimicry is associated with trastuzumab resistance of HER2-positive breast cancer
por: Hori, Ami, et al.
Publicado: (2019)

Successful Concurrent Chemoradiotherapy with Cisplatin plus Vinorelbine for Locally Advanced Thymic Carcinoma
por: Fukushima, Toshirou, et al.
Publicado: (2014)

Increased carbohydrate antigen 19‐9 expression in a thymic neuroendocrine tumor
por: Shimizu, Yuki, et al.
Publicado: (2021)

Successful Response to Cyclophosphamide, Vincristine, and Dacarbazine Chemotherapy in a Patient with Metastatic Carotid Body Paraganglioma
por: Yamada, Hiroki, et al.
Publicado: (2021)

Metastatic Salivary Duct Carcinoma with ERBB2 Amplification and Sequential Response to Ado-Trastuzumab Emtansine and Neratinib: A Case Report
por: Asper, Nora, et al.
Publicado: (2023)

Efficacy of Pyrotinib in HER2-Overexpressing Salivary Duct Carcinoma With Lung Metastasis: A Case Report
por: Yang, Zi-yan, et al.
Publicado: (2020)

Effect of Trastuzumab–HER2 Complex Formation on Stress-Induced Modifications in the CDRs of Trastuzumab
por: Spanov, Baubek, et al.
Publicado: (2022)

HER2 therapy: Molecular mechanisms of trastuzumab resistance
por: Nahta, Rita, et al.
Publicado: (2006)

Targeting HER2 in breast cancer: beyond trastuzumab
por: Winer, EP
Publicado: (2011)

Quantification of Trastuzumab–HER2 Engagement In Vitro and In Vivo
por: Rudkouskaya, Alena, et al.
Publicado: (2020)

Pathological complete response to neoadjuvant trastuzumab and pertuzumab therapy is related to human epidermal growth factor receptor 2 (HER2) amplification level in HER2-amplified breast cancer
por: Choi, Jin Hyuk, et al.
Publicado: (2020)

The in vitro influences of epidermal growth factor and heregulin-β1 on the efficacy of trastuzumab used in Her-2 positive breast adenocarcinoma
por: Hurrell, Tracey, et al.
Publicado: (2013)

The efficacy of amrubicin third‐line chemotherapy in patients with relapsed extensive‐disease small‐cell lung cancer: A retrospective and historical study in a single institute
por: Sonehara, Kei, et al.
Publicado: (2019)

Direct Intraesophageal Growth from Metastatic Mediastinal Lymphadenopathy in Thymic Carcinoma
por: Kanazawa, Hiroki, et al.
Publicado: (2020)

Syndrome of Inappropriate Antidiuretic Hormone Secretion as the Initial Presentation in a Patient with Stage I Small-cell Lung Cancer
por: Koizumi, Tomonobu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_op27lftkp8b8f7qbpksmkd75r0